Yun Zhong's Stock Ratings

Wedbush Analyst

Yun Zhong is an analyst at Wedbush. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 11/21/2024

Overall Average Return

-8.31%

Smart Score

43.9%

Overall Average Return Percentile

22nd

Number of Ratings

44
Data brought to you by Benzinga APIs

Recent Analyst Stock Rating News

Biotech Stock On The Radar: Anavex, A Neurology-Focused Precision Medicine Company
Janney: Amicus Therapeutics Has Significant Upside From Gene Therapy Pipeline
Analysts Laud Sarepta's 'Increasingly Active' Gene Therapy Clinical Development
Janney: Cannabis, Naloxone, Adrenaline The Perfect Mix For Insys
Janney, Morgan Stanley Say Sarepta's Gene Therapy Remains on Track
Analyst: Insys To Benefit As FDA Pushes Naloxone Access
Janney Upgrades bluebird bio Ahead Of Sickle Cell Presentation
Janney: Nightstar Therapeutics Has 'Significant Upside Potential' With Retinal Disorder Treatments
Janney: 4 Reasons Why Selecta Biosciences Is 'Significantly Undervalued'
Summit Therapeutics' Upcoming Duchenne Muscular Dystrophy Data 'A Strong Catalyst,' Janney Says In Bullish Initiation
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved